Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke (SPARCL)

Pfizer

Status and phase: Completed; Phase 4

Conditions: Cardiovascular Disease

Treatments: Drug: atorvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00147602

A2581138

0981-342

Details and patient eligibility

About

To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Previous stroke or TIA

Exclusion criteria

• coronary heart disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind